SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 49 filers reported holding SQZ BIOTECHNOLOGIES CO in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129 | -70.3% | 1,606,309 | 0.0% | 0.01% | -53.8% |
| Q2 2023 | $434 | -51.8% | 1,606,309 | 0.0% | 0.01% | -75.5% |
| Q1 2023 | $900 | -24.3% | 1,606,309 | 0.0% | 0.05% | -19.7% |
| Q4 2022 | $1,189 | -100.0% | 1,606,309 | 0.0% | 0.07% | -57.7% |
| Q3 2022 | $3,662,000 | -28.3% | 1,606,309 | 0.0% | 0.16% | -42.9% |
| Q2 2022 | $5,108,000 | -33.9% | 1,606,309 | 0.0% | 0.27% | -15.5% |
| Q1 2022 | $7,726,000 | -46.1% | 1,606,309 | 0.0% | 0.32% | -17.0% |
| Q4 2021 | $14,344,000 | -38.1% | 1,606,309 | 0.0% | 0.39% | -24.9% |
| Q3 2021 | $23,163,000 | -0.2% | 1,606,309 | 0.0% | 0.52% | +10.0% |
| Q2 2021 | $23,211,000 | +5.6% | 1,606,309 | 0.0% | 0.47% | +21.4% |
| Q1 2021 | $21,974,000 | -52.8% | 1,606,309 | +0.0% | 0.39% | -61.2% |
| Q4 2020 | $46,551,000 | – | 1,606,308 | – | 1.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 1,606,309 | $900 | 0.05% |
| Sandy Cove Advisors, LLC | 51,707 | $28,956 | 0.02% |
| MAVERICK CAPITAL LTD | 1,051,771 | $588,992 | 0.02% |
| Temasek Holdings (Private) Ltd | 2,758,169 | $1,544,575 | 0.01% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,517,173 | $1,409,617 | 0.01% |
| RBF Capital, LLC | 74,674 | $41,817 | 0.00% |
| Laurion Capital Management LP | 431,400 | $241,584 | 0.00% |
| Virtu Financial LLC | 17,075 | $10 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 65,800 | $36,848 | 0.00% |
| Bangor Savings Bank | 11,357 | $6,360 | 0.00% |